✦ LIBER ✦

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty-two–week, randomized, controlled study

✍ Scribed by Désirée van der Heijde; Herbert S. B. Baraf; Cesar Ramos-Remus; Andrei Calin; Arthur L. Weaver; Michael Schiff; Margaret James; Jan E. Markind; Alise S. Reicin; Agustin Melian; Maxime Dougados

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 255 KB
Volume: 52
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.20985

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of infliximab in pat

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)

✍ Désirée van der Heijde; Ben Dijkmans; Piet Geusens; Joachim Sieper; Kimberly DeW 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Circulating concentration of infliximab

Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: Results from a randomized control study

✍ Krzysiek, Roman ;Breban, Maxime ;Ravaud, Philippe ;Prejean, Maria Vittoria ;Wijd 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Adalimumab reduces spinal symptoms in ac

Adalimumab reduces spinal symptoms in active ankylosing spondylitis: Clinical and magnetic resonance imaging results of a fifty-two–week open-label trial

✍ Hildrun Haibel; Martin Rudwaleit; Henning C. Brandt; Zarho Grozdanovic; Joachim 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

✍ Oliver Distler; Wolfgang Eich; Eva Dokoupilova; Zdenek Dvorak; Martin Fleck; Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views